PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21400615-4	2011	Western blot analysis revealed that 5"-NIO inhibited activities of Raf-1 (S338), MEK1/2, ERK1/2, JNK, and c-Jun induced by EGF or TPA, respectively, whereas it did not affect autophosphorylation of epidermal growth factor receptor (EGFR) induced by EGF or TPA.	Tetradecanoylphorbol Acetate	130-133	jun proto-oncogene	Mus musculus	106-111	
21400615-5	2011	In addition, 5"-NIO exerted strong inhibitory effects on the EGF- or TPA-induced c-fos or c-jun transcriptional activity, and thereby inhibited the associated activator protein-1 (AP-1) transactivation activity induced by EGF or TPA.	Tetradecanoylphorbol Acetate	69-72	jun proto-oncogene	Mus musculus	90-95	
21400615-5	2011	In addition, 5"-NIO exerted strong inhibitory effects on the EGF- or TPA-induced c-fos or c-jun transcriptional activity, and thereby inhibited the associated activator protein-1 (AP-1) transactivation activity induced by EGF or TPA.	Tetradecanoylphorbol Acetate	69-72	jun proto-oncogene	Mus musculus	159-178	
21400615-5	2011	In addition, 5"-NIO exerted strong inhibitory effects on the EGF- or TPA-induced c-fos or c-jun transcriptional activity, and thereby inhibited the associated activator protein-1 (AP-1) transactivation activity induced by EGF or TPA.	Tetradecanoylphorbol Acetate	69-72	jun proto-oncogene	Mus musculus	180-184	
21400615-5	2011	In addition, 5"-NIO exerted strong inhibitory effects on the EGF- or TPA-induced c-fos or c-jun transcriptional activity, and thereby inhibited the associated activator protein-1 (AP-1) transactivation activity induced by EGF or TPA.	Tetradecanoylphorbol Acetate	229-232	jun proto-oncogene	Mus musculus	159-178	
21400615-5	2011	In addition, 5"-NIO exerted strong inhibitory effects on the EGF- or TPA-induced c-fos or c-jun transcriptional activity, and thereby inhibited the associated activator protein-1 (AP-1) transactivation activity induced by EGF or TPA.	Tetradecanoylphorbol Acetate	229-232	jun proto-oncogene	Mus musculus	180-184